![Mann Muhsin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mann Muhsin worked as a Medical Director-Oncology Clinical Development at Halozyme Therapeutics, Inc. from 2016 to 2019.
He then worked as a Senior VP-Oncology Clinical Development at HUYA Bioscience International LLC from 2019 to 2020.
In 2021, he became the Chief Medical Officer at Medicenna Therapeutics Corp.
Dr. Muhsin earned a doctorate degree from the University of Baghdad.
Anciens postes connus de Mann Muhsin
| Sociétés | Poste | Fin |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Directeur Technique/Scientifique/R&D | 17/01/2022 |
Huyabio International LLC
 Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Corporate Officer/Principal | 01/04/2020 |
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2019 |
Formation de Mann Muhsin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
University of Baghdad
 University of Baghdad Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
